
pmid: 35385160
AbstractCancer is one of the most intractable diseases owing to its high mortality rate and lack of effective diagnostic and treatment tools. Advancements in micro‐/nanorobot (MNR)‐assisted sensing, imaging, and therapeutics offer unprecedented opportunities to develop MNR‐based cancer theragnostic platforms. Unlike ordinary nanoparticles, which exhibit Brownian motion in biofluids, MNRs overcome viscous resistance in an ultralow Reynolds number (Re << 1) environment by effective self‐propulsion. This unique locomotion property has motivated the advanced design and functionalization of MNRs as a basis for next‐generation cancer‐therapy platforms, which offer the potential for precise distribution and improved permeation of therapeutic agents. Enhanced barrier penetration, imaging‐guided operation, and biosensing are additionally studied to enable the promising cancer‐related applications of MNRs. Herein, the recent advances in MNR‐based cancer therapy are comprehensively addresses, including actuation engines, diagnostics, medical imaging, and targeted drug delivery; promising research opportunities that can have a profound impact on cancer therapy over the next decade is highlighted.
Drug Delivery Systems, Neoplasms, Humans, Nanoparticles
Drug Delivery Systems, Neoplasms, Humans, Nanoparticles
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 108 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
